| David Robert Beckert, MD | |
|
171 Ashley Ave, Charleston, SC 29425-0001 | |
| (843) 792-1414 | |
| Not Available |
| Full Name | David Robert Beckert |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 18 Years |
| Location | 171 Ashley Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154403475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 28882 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
Antisense therapeutics, a class of drugs comprised of short nucleic acid sequences, can target a dysfunctional gene and silence its activity. A new study has shown that antisense drugs delivered systemically show activity in a wide range of tissues and organs, supporting their broad therapeutic potential in many disease indications, as described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
Antisense therapeutics, a class of drugs comprised of short nucleic acid sequences, can target a dysfunctional gene and silence its activity. A new study has shown that antisense drugs delivered systemically show activity in a wide range of tissues and organs, supporting their broad therapeutic potential in many disease indications, as described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Entity Name | South Carolina Dept Of Mental Health Accounting Office |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760596480 PECOS PAC ID: 9032021175 Enrollment ID: O20031215000552 |
News Archive
The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
Antisense therapeutics, a class of drugs comprised of short nucleic acid sequences, can target a dysfunctional gene and silence its activity. A new study has shown that antisense drugs delivered systemically show activity in a wide range of tissues and organs, supporting their broad therapeutic potential in many disease indications, as described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Robert Beckert, MD Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | David Robert Beckert, MD 171 Ashley Ave, Charleston, SC 29425-0001 Ph: (843) 792-1414 |
News Archive
The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.
A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."
Antisense therapeutics, a class of drugs comprised of short nucleic acid sequences, can target a dysfunctional gene and silence its activity. A new study has shown that antisense drugs delivered systemically show activity in a wide range of tissues and organs, supporting their broad therapeutic potential in many disease indications, as described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
Christine Lloyd, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 198 Rutledge Ave, Charleston, SC 29403 Phone: 843-577-5012 Fax: 843-722-8368 | |
Robert Joseph Adams, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 Fax: 843-792-2484 | |
Kevin Michael Gray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Melanie Anne Lobel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Billy Beck, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Ciara Monet Styles, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-9888 | |
Alexandra Goslow, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-9888 |